CD274 and neoplasm: Emerging clinical data and experimental studies have highlighted the PD-L1 expression in tumor is upregulated in response to various anti-tumor therapies, such as chemotherapy 19, radiotherapy 20, PDT 21, PTT 22, SDT 23, CAR-T 24, oncolytic virus therapy 25 and other immunotherapies 26.